Stay updated on Topical BMX-010 in Skin Diseases Clinical Trial
Sign up to get notified when there's something new on the Topical BMX-010 in Skin Diseases Clinical Trial page.

Latest updates to the Topical BMX-010 in Skin Diseases Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 is now shown, and the funding-lapse notice and Revision: v3.4.1 have been removed.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a site-wide government funding/operating status notice and updated the page revision to v3.4.1 (from v3.4.0).SummaryDifference0.4%

- Check28 days agoChange DetectedThe page now shows a glossary toggle and updated metadata labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0), while corresponding previous labels/texts were removed or altered (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedThe update is a minor revision change from v3.3.3 to v3.3.4 in the site footer, with no changes to the study details or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded a consolidated Locations section listing California, Colorado, Florida, Indiana, New York, South Carolina, Tennessee, and Texas, and removed the separate state-location entries. The page revision was updated to v3.3.3.SummaryDifference1%

- Check92 days agoChange DetectedRevision: v3.3.2 was added and v3.2.0 was removed in the page revision history, with no substantive changes to the study details, eligibility criteria, outcomes, or locations.SummaryDifference0.1%

Stay in the know with updates to Topical BMX-010 in Skin Diseases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Topical BMX-010 in Skin Diseases Clinical Trial page.